Ortin Global Limited (NSE:ORTINGLOBE)

Market Cap	106.08M +10.7%
Revenue (ttm)	356.00K -79.5%
Net Income	-9.03M
EPS	-1.11
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,432
Open	13.00
Previous Close	13.98
Day's Range	13.00 - 14.45
52-Week Range	11.00 - 21.30
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 8
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORTINGLOBE

Financial Performance

In fiscal year 2026, Ortin Global's revenue was 1.08 million, a decrease of -68.35% compared to the previous year's 3.43 million. Losses were -7.40 million, -12.52% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error